DK1128826T3 - Chromonformulering til enteral frigørelse af aktivt stof - Google Patents
Chromonformulering til enteral frigørelse af aktivt stofInfo
- Publication number
- DK1128826T3 DK1128826T3 DK99954194T DK99954194T DK1128826T3 DK 1128826 T3 DK1128826 T3 DK 1128826T3 DK 99954194 T DK99954194 T DK 99954194T DK 99954194 T DK99954194 T DK 99954194T DK 1128826 T3 DK1128826 T3 DK 1128826T3
- Authority
- DK
- Denmark
- Prior art keywords
- chromone
- formulation
- active substance
- enteral release
- enteral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Manufacturing Of Magnetic Record Carriers (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9824604.4A GB9824604D0 (en) | 1998-11-11 | 1998-11-11 | Treatment of allergic conditions |
| PCT/GB1999/003731 WO2000027392A1 (en) | 1998-11-11 | 1999-11-09 | Chromone enteric release formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1128826T3 true DK1128826T3 (da) | 2004-04-05 |
Family
ID=10842171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99954194T DK1128826T3 (da) | 1998-11-11 | 1999-11-09 | Chromonformulering til enteral frigørelse af aktivt stof |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7258872B1 (de) |
| EP (1) | EP1128826B1 (de) |
| JP (1) | JP4558207B2 (de) |
| AT (1) | ATE258049T1 (de) |
| AU (1) | AU1061400A (de) |
| CA (1) | CA2350519C (de) |
| DE (1) | DE69914360T2 (de) |
| DK (1) | DK1128826T3 (de) |
| ES (1) | ES2219075T3 (de) |
| GB (1) | GB9824604D0 (de) |
| PT (1) | PT1128826E (de) |
| WO (1) | WO2000027392A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9824604D0 (en) * | 1998-11-11 | 1999-01-06 | Hewlett Healthcare Limited | Treatment of allergic conditions |
| US20040115236A1 (en) * | 2000-10-06 | 2004-06-17 | Chan Tai Wah | Devices and methods for management of inflammation |
| US7316819B2 (en) * | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
| JP5196701B2 (ja) * | 2001-11-29 | 2013-05-15 | エミスフィアー テクノロジーズ インコーポレイテッド | クロモリンナトリウムの経口投与用製剤 |
| US8263645B2 (en) * | 2006-02-03 | 2012-09-11 | Pari Pharma Gmbh | Disodium cromoglycate compositions and methods for administering same |
| US8817116B2 (en) | 2011-10-28 | 2014-08-26 | Lg Innotek Co., Ltd. | Camera module |
| EP3725311A1 (de) | 2014-02-10 | 2020-10-21 | Respivant Sciences GmbH | Verfahren zur behandlung von lungenerkrankungen mit mastzellstabilisatoren |
| SI3104853T1 (sl) | 2014-02-10 | 2020-03-31 | Respivant Sciences Gmbh | Zdravljenje s stabilizatorji mastocitov za sistemske motnje |
| US10238625B2 (en) | 2015-08-07 | 2019-03-26 | Respivant Sciences Gmbh | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
| WO2017027402A1 (en) | 2015-08-07 | 2017-02-16 | Patara Pharma, LLC | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
| CN110139646A (zh) | 2016-08-31 | 2019-08-16 | 瑞思皮万特科学有限责任公司 | 用于治疗由特发性肺纤维化引起的慢性咳嗽的色甘酸组合物 |
| AU2017339366A1 (en) | 2016-10-07 | 2019-04-11 | Respivant Sciences Gmbh | Cromolyn compositions for treatment of pulmonary fibrosis |
| IT201700030541A1 (it) | 2017-03-20 | 2018-09-20 | Federica Livieri | Composizione e kit per uso nella prevenzione dell’onicomicosi recidivante |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1423985A (en) | 1972-02-15 | 1976-02-04 | Fisons Ltd | Pharmaceutical compositions containing bischromonyloxy compounds |
| US4067992A (en) | 1975-09-10 | 1978-01-10 | Fisons Limited | Method of treating a psychiatric condition |
| GB1525294A (en) | 1976-06-22 | 1978-09-20 | Fisons Ltd | Compositions containing substituted bis-chromonyl compounds |
| GB1549229A (en) | 1976-09-23 | 1979-08-01 | Fisons Ltd | High density sodium cromoglycate |
| GB1569612A (en) | 1977-01-13 | 1980-06-18 | Fisons Ltd | Disodium cromoglycate pellets or granules |
| GB1557082A (en) | 1977-01-25 | 1979-12-05 | Fisons Ltd | Pharmaceutical mixture containing an antiinflammatory |
| GB1595220A (en) | 1977-12-23 | 1981-08-12 | Fisons Ltd | Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane |
| GB2086227B (en) | 1980-11-05 | 1984-10-10 | Fisons Ltd | Sodium cromoglycate reconstitutable powders |
| SE8303401D0 (sv) * | 1983-06-15 | 1983-06-15 | Pharmacia Ab | Beredning och dess anvendning |
| SE8903914D0 (sv) | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
| DK66493D0 (da) | 1993-06-08 | 1993-06-08 | Ferring A S | Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling |
| GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| GB9709451D0 (en) | 1997-05-10 | 1997-07-02 | Hewlett Healthcare Limited | Treatment of allergic conditions |
| GB2324962B (en) * | 1997-05-10 | 2001-10-03 | Hewlett Healthcare Ltd | Treatment of allergic conditions |
| GB9824604D0 (en) * | 1998-11-11 | 1999-01-06 | Hewlett Healthcare Limited | Treatment of allergic conditions |
| DE19900116C2 (de) | 1999-01-05 | 2002-02-14 | Univ Muenchen Tech | Vorrichtung zum Erzeugen von Brenngas durch allotherme Vergasung von Biomasse |
-
1998
- 1998-11-11 GB GBGB9824604.4A patent/GB9824604D0/en not_active Ceased
-
1999
- 1999-11-09 EP EP99954194A patent/EP1128826B1/de not_active Expired - Lifetime
- 1999-11-09 DK DK99954194T patent/DK1128826T3/da active
- 1999-11-09 PT PT99954194T patent/PT1128826E/pt unknown
- 1999-11-09 US US09/831,681 patent/US7258872B1/en not_active Expired - Fee Related
- 1999-11-09 AU AU10614/00A patent/AU1061400A/en not_active Abandoned
- 1999-11-09 ES ES99954194T patent/ES2219075T3/es not_active Expired - Lifetime
- 1999-11-09 CA CA2350519A patent/CA2350519C/en not_active Expired - Fee Related
- 1999-11-09 WO PCT/GB1999/003731 patent/WO2000027392A1/en active IP Right Grant
- 1999-11-09 AT AT99954194T patent/ATE258049T1/de active
- 1999-11-09 DE DE69914360T patent/DE69914360T2/de not_active Expired - Lifetime
- 1999-11-09 JP JP2000580621A patent/JP4558207B2/ja not_active Expired - Fee Related
-
2006
- 2006-10-13 US US11/580,511 patent/US20070036860A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1128826E (pt) | 2004-06-30 |
| DE69914360T2 (de) | 2004-11-11 |
| EP1128826A1 (de) | 2001-09-05 |
| AU1061400A (en) | 2000-05-29 |
| WO2000027392A1 (en) | 2000-05-18 |
| JP4558207B2 (ja) | 2010-10-06 |
| DE69914360D1 (de) | 2004-02-26 |
| US20070036860A1 (en) | 2007-02-15 |
| CA2350519A1 (en) | 2000-05-18 |
| CA2350519C (en) | 2011-09-13 |
| GB9824604D0 (en) | 1999-01-06 |
| ES2219075T3 (es) | 2004-11-16 |
| ATE258049T1 (de) | 2004-02-15 |
| JP2002529413A (ja) | 2002-09-10 |
| EP1128826B1 (de) | 2004-01-21 |
| US7258872B1 (en) | 2007-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1128826T3 (da) | Chromonformulering til enteral frigørelse af aktivt stof | |
| Al-Harbi et al. | Carbon tetrachloride-induced hepatotoxicity in rat is reversed by treatment with riboflavin | |
| NO20021830L (no) | Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav | |
| Akamo et al. | Naringin prevents cyclophosphamide-induced hepatotoxicity in rats by attenuating oxidative stress, fibrosis, and inflammation | |
| BR0307755A (pt) | Tratamento de resfriados e tosse com uma combinação de um inibidor seletivo da ciclooxigenase-2 e um ingrediente ativo contra resfriados e tosse e composições dos mesmos | |
| NO20061911L (no) | Immunogene sammensetninger | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| DK1556058T3 (da) | Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi | |
| PT1347971E (pt) | Inibidores tiazolilicos de tirosina-cinases da familia tec | |
| DE60327438D1 (de) | Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen | |
| Dubey et al. | Rutin exerts antiulcer effect by inhibiting the gastric proton pump | |
| HUP0401501A2 (hu) | Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával | |
| Sajjadi et al. | Comparative study on the preventive effect of saffron carotenoids, crocin and crocetin, in NMU-induced breast cancer in rats | |
| WO2002040702A3 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
| Motawea et al. | Evaluation of anti-inflammatory and antioxidant profile of oleuropein in experimentally induced ulcerative colitis | |
| DE602007010018D1 (de) | PHARMAZEUTISCHE ZUSAMMENSETZUNG enthaltend CORDYCEPIN ZUR BEHANDLUNG UND PRÄVENTION VON FETTleibigkeit | |
| Huang et al. | Sulfation of dietary flavonoids by human sulfotransferases | |
| NO20054670D0 (no) | Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid | |
| Wu et al. | Preventive effect of flavonoid extract from the peel of Gonggan (Citrus reticulata Blanco Var. Gonggan) on CCl4-induced acute liver injury in mice | |
| NO20042199L (no) | Lav peroksydkonsentrasjon for behandling eller forebygging av vaginale infeksjoner | |
| Yao et al. | Effect of deep eutectic solvent extraction on Auricularia auricula polysaccharide solubilization and antioxidant potential | |
| MX2009004142A (es) | Metodo para prevenir o tratar sindrome metabolico. | |
| EP1533313A4 (de) | Neues derivat von flavon-c-glycosid und zusammensetzung, die dieses enthült | |
| NO20023117L (no) | Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former | |
| ATE339962T1 (de) | Zubereitungen zur behandlung von lupus |